Effect of deferoxamine and hyperbaric oxygen on free, autogenous, full-thickness skin grafts in dogs.
Free, autogenous, full-thickness skin grafts were applied to 10 dogs; 5 dogs were given an iron chelator, deferoxamine-10% hydroxyethyl pentafraction starch (DEF-HES; 50 mg/kg of body weight, IV), and 5 dogs were given an equal volume of 10% hydroxyethyl pentafraction starch (HES) in 0.9% saline solution (5 ml/kg, IV). All dogs (DEF-HES/HBO- and HES/HBO-treated) were exposed to 60 minutes of hyperbaric oxygen (HBO) at 2 atmospheres absolute pressure twice daily for 10 days, beginning the day of surgery. The percentage of viable graft on day 10 was lower in HES/HBO-treated dogs (mean +/- SD, 13.3 +/- 21.3%; median, 3.0%) than in DEF-HES/HBO-treated dogs (64.7 +/- 39.2%; 88.3%; P = 0.095, Mann-Whitney two-tailed test). There was a positive correlation between percentage of viable graft (on day 10) and percentage of haired skin on the graft site (on day 28) for all dogs (r = 0.91) and for HES/HBO-treated dogs (r = 0.97). The DEF-HES/HBO-treated dogs had less consistent correlation (r = 0.67). Perivascular aggregates of foamy cells were observed in the superficial and reticular portions of the dermis and in the subcutaneous tissue on both surfaces of the panniculus muscle in the graft sites of DEF-HES/HBO-treated dogs. These cells were also observed in the dermis, but not subcutaneous tissue of the control skin sections, and in some viscera of DEF-HES/HBO-treated dogs. Deferoxamine appears to attenuate the detrimental effect of HBO and HES on survival of free skin grafts.(ABSTRACT TRUNCATED AT 250 WORDS)
Hosgood
G
G
Department of Veterinary Clinical Sciences, Louisiana State University, Baton Rouge 70803, USA.
Hodgin
E C
EC
Strain
G M
GM
Lopez
M K
MK
Lewis
D D
DD
D000818:Animals; D003676:Deferoxamine / Q000494:pharmacology*; D004285:Dogs / Q000601:surgery*; D005260:Female; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D006931:Hyperbaric Oxygenation / Q000662:veterinary*; D016038:Skin Transplantation / Q000502:physiology / Q000662:veterinary*; D014182:Transplantation, Autologous / Q000502:physiology / Q000662:veterinary
D003676:Deferoxamine